BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23385593)

  • 1. Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer.
    Di LJ; Byun JS; Wong MM; Wakano C; Taylor T; Bilke S; Baek S; Hunter K; Yang H; Lee M; Zvosec C; Khramtsova G; Cheng F; Perou CM; Miller CR; Raab R; Olopade OI; Gardner K
    Nat Commun; 2013; 4():1449. PubMed ID: 23385593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic re-wiring of breast cancer by pharmacological targeting of C-terminal binding protein.
    Byun JS; Park S; Yi DI; Shin JH; Hernandez SG; Hewitt SM; Nicklaus MC; Peach ML; Guasch L; Tang B; Wakefield LM; Yan T; Caban A; Jones A; Kabbout M; Vohra N; Nápoles AM; Singhal S; Yancey R; De Siervi A; Gardner K
    Cell Death Dis; 2019 Sep; 10(10):689. PubMed ID: 31534138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated gene expression profiling and chromatin immunoprecipitation followed by sequencing: Analysis of the C-terminal binding protein in breast cancer.
    Chen L; Yang Y; Xu L; Liu R; Wang Y
    J Obstet Gynaecol Res; 2017 Sep; 43(9):1472-1480. PubMed ID: 28613020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization.
    Banerjee A; Birts CN; Darley M; Parker R; Mirnezami AH; West J; Cutress RI; Beers SA; Rose-Zerilli MJJ; Blaydes JP
    Carcinogenesis; 2019 Jul; 40(7):871-882. PubMed ID: 30668646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCRIP1, an ERK substrate, mediates ERK-induced gene silencing during epithelial-mesenchymal transition by regulating the co-repressor CtBP.
    Ichikawa K; Kubota Y; Nakamura T; Weng JS; Tomida T; Saito H; Takekawa M
    Mol Cell; 2015 Apr; 58(1):35-46. PubMed ID: 25728771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.
    Birts CN; Harding R; Soosaipillai G; Halder T; Azim-Araghi A; Darley M; Cutress RI; Bateman AC; Blaydes JP
    Biol Cell; 2010 Jan; 103(1):1-19. PubMed ID: 20964627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycolysis, via NADH-dependent dimerisation of CtBPs, regulates hypoxia-induced expression of CAIX and stem-like breast cancer cell survival.
    Kreuzer M; Banerjee A; Birts CN; Darley M; Tavassoli A; Ivan M; Blaydes JP
    FEBS Lett; 2020 Sep; 594(18):2988-3001. PubMed ID: 32618367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors.
    Dcona MM; Morris BL; Ellis KC; Grossman SR
    Cancer Biol Ther; 2017 Jun; 18(6):379-391. PubMed ID: 28532298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance.
    Tsou SH; Chen TM; Hsiao HT; Chen YH
    PLoS One; 2015; 10(1):e0116747. PubMed ID: 25635866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation by C-terminal binding proteins.
    Chinnadurai G
    Int J Biochem Cell Biol; 2007; 39(9):1593-607. PubMed ID: 17336131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells.
    Guha M; Srinivasan S; Ruthel G; Kashina AK; Carstens RP; Mendoza A; Khanna C; Van Winkle T; Avadhani NG
    Oncogene; 2014 Nov; 33(45):5238-50. PubMed ID: 24186204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAD-linked mechanisms of gene de-repression and a novel role for CtBP in persistent adenovirus infection of lymphocytes.
    Dickherber ML; Garnett-Benson C
    Virol J; 2019 Dec; 16(1):161. PubMed ID: 31864392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Molecule, NSC95397, Inhibits the CtBP1-Protein Partner Interaction and CtBP1-Mediated Transcriptional Repression.
    Blevins MA; Kouznetsova J; Krueger AB; King R; Griner LM; Hu X; Southall N; Marugan JJ; Zhang Q; Ferrer M; Zhao R
    J Biomol Screen; 2015 Jun; 20(5):663-72. PubMed ID: 25477201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of C-terminal binding protein attenuates transcription factor 4 signaling to selectively target colon cancer stem cells.
    Patel J; Baranwal S; Love IM; Patel NJ; Grossman SR; Patel BB
    Cell Cycle; 2014; 13(22):3506-18. PubMed ID: 25483087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy.
    Pervin S; Hewison M; Braga M; Tran L; Chun R; Karam A; Chaudhuri G; Norris K; Singh R
    PLoS One; 2013; 8(1):e53287. PubMed ID: 23341935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoma-derived growth factor represses SET and MYND domain containing 1 gene expression through interaction with C-terminal binding protein.
    Yang J; Everett AD
    J Mol Biol; 2009 Mar; 386(4):938-50. PubMed ID: 19162039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-β signaling.
    Zhao Z; Hao D; Wang L; Li J; Meng Y; Li P; Wang Y; Zhang C; Zhou H; Gardner K; Di LJ
    Oncogene; 2019 Mar; 38(12):2076-2091. PubMed ID: 30442980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional co-repressor CtBP2 orchestrates epithelial-mesenchymal transition through a novel transcriptional holocomplex with OCT1.
    Ma Y; Sekiya M; Kainoh K; Matsuda T; Iwasaki H; Osaki Y; Sugano Y; Suzuki H; Takeuchi Y; Miyamoto T; Yahagi N; Nakagawa Y; Matsuzaka T; Shimano H
    Biochem Biophys Res Commun; 2020 Mar; 523(2):354-360. PubMed ID: 31866012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP.
    Shen Y; Kapfhamer D; Minnella AM; Kim JE; Won SJ; Chen Y; Huang Y; Low LH; Massa SM; Swanson RA
    Nat Commun; 2017 Sep; 8(1):624. PubMed ID: 28935892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ARF/CtBP2 complex regulates BH3-only gene expression and p53-independent apoptosis.
    Kovi RC; Paliwal S; Pande S; Grossman SR
    Cell Death Differ; 2010 Mar; 17(3):513-21. PubMed ID: 19798104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.